These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 25007362)
1. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials. Elewski BE; Vlahovic TC J Drugs Dermatol; 2014 Jul; 13(7):803-8. PubMed ID: 25007362 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials. Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165 [TBL] [Abstract][Full Text] [Related]
3. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis. Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826 [TBL] [Abstract][Full Text] [Related]
4. Econazole Nitrate Foam 1% Improves the Itch of Tinea Pedis. Fleischer AB; Raymond I J Drugs Dermatol; 2016 Sep; 15(9):1111-4. PubMed ID: 27602974 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Signs and Symptoms (Pruritus) of Interdigital Tinea Pedis With Econazole Nitrate Foam, 1. Hoffman LK; Raymond I; Kircik L J Drugs Dermatol; 2018 Feb; 17(2):229-232. PubMed ID: 29462232 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study. Jarratt M; Jones T; Adelglass J; Bucko A; Pollak R; Roman-Miranda A; Olin JT; Swinyer L J Drugs Dermatol; 2014 Jul; 13(7):838-46. PubMed ID: 25007368 [TBL] [Abstract][Full Text] [Related]
7. The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis. Savin R; Jorizzo J Cutis; 2006 Oct; 78(4):268-74. PubMed ID: 17121064 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial. Gupta AK; Skinner AR; Cooper EA Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032 [TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis. Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309 [TBL] [Abstract][Full Text] [Related]
10. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial. Savin R; De Villez RL; Elewski B; Hong S; Jones T; Lowe N; Lucky A; Reyes B; Stewart D; Willis I J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200 [TBL] [Abstract][Full Text] [Related]
11. A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea Pedis. Elewski BE; Kircik LH; Stasko N; De Leon E; Enloe C; Durham T; Maeda-Chubachi T J Drugs Dermatol; 2018 Aug; 17(8):888-893. PubMed ID: 30124729 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050 [TBL] [Abstract][Full Text] [Related]
13. Luliconazole for the treatment of interdigital tinea pedis: A double-blind, vehicle-controlled study. Jarratt M; Jones T; Kempers S; Rich P; Morton K; Nakamura N; Tavakkol A Cutis; 2013 Apr; 91(4):203-10. PubMed ID: 23763082 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris. Parish LC; Parish JL; Routh HB; Avakian E; Olayinka B; Pappert EJ; Plaum S; Fleischer AB; Hardas B J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664 [TBL] [Abstract][Full Text] [Related]
15. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis. Korting HC; Kiencke P; Nelles S; Rychlik R Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018 [TBL] [Abstract][Full Text] [Related]
16. Ciclopirox gel in the treatment of patients with interdigital tinea pedis. Aly R; Fisher G; Katz I; Levine N; Lookingbill DP; Lowe N; Menter A; Morman M; Pariser DM; Roth HL; Savin RC; Shavin JS; Stewart D; Taylor JR; Tucker S; Wortzman M Int J Dermatol; 2003 Sep; 42 Suppl 1():29-35. PubMed ID: 14567368 [TBL] [Abstract][Full Text] [Related]
17. Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis. Markinson B; Caldwell B J Am Podiatr Med Assoc; 2015 Sep; 105(5):407-11. PubMed ID: 26429609 [TBL] [Abstract][Full Text] [Related]
18. Comparison of an antifungal agent used alone with an antifungal used with a topical steroid in inflammatory tinea pedis. Elewski BE; Jones T; Zaias N Cutis; 1996 Oct; 58(4):305-7. PubMed ID: 8894432 [TBL] [Abstract][Full Text] [Related]
19. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent. Jegasothy BV; Pakes GE Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris. Lebwohl M; Elewski B; Eisen D; Savin RC Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]